Catalyst Pharmaceuticals Inc (CPRX)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	398,204	214,203	140,833	119,073	102,306
Property, plant and equipment	US$ in thousands	1,195	847	959	130	210
Fixed asset turnover		333.23	252.90	146.85	915.95	487.17

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $398,204K ÷ $1,195K
= 333.23

The fixed asset turnover ratio for Catalyst Pharmaceuticals Inc has exhibited significant fluctuations over the past five years. In 2023, the company achieved a fixed asset turnover of 333.23, indicating that for every dollar invested in fixed assets, the company generated approximately $333.23 in revenue. This represents a substantial improvement from the previous year's ratio of 252.90.

However, it is important to note that the fixed asset turnover ratio in 2023 was significantly higher compared to the ratios in 2021 and 2019, which were 146.85 and 487.17 respectively. This suggests that Catalyst Pharmaceuticals Inc experienced a notable efficiency improvement in utilizing its fixed assets to generate revenue in 2023.

Overall, the trend in the fixed asset turnover ratio for Catalyst Pharmaceuticals Inc indicates variability in the efficiency of the company's utilization of fixed assets to generate revenue over the past five years. Further analysis of the company's operational and financial performance is recommended to determine the factors contributing to these fluctuations.